According to research recently published by the journal Science Traslational Medicine, the hepatitis C virus (known as HCV) has become an interesting tool when faced with rejection in liver transplant patients.
As reported by the abovementioned study, 50% of people infected with hepatitis C (17 out of a total of 34) who underwent transplantation were able to maintain the performance of their new liver, even after they stopped taking immunosuppressive drugs – a type of drug administered to this type of patient so that their body does not recognise the transplanted organ as a foreign entity, with the risk of rejection that this implies.This is a situation, which, in spite of the high percentage of patients in whom it works (50% of cases), has no clinical application. In view of the fact that the risk of rejection disappeared in one out of two patients - as shown in the investigation - hepatitis C infection could cause the rapid onset of cirrhosis in the transplanted organ. In any event, it is possible that this research may become a discovery that brings to light part of the unknown behaviour of our immune system. An investigation that offers not only new answers, but also new questions According to Read more